Liz Rogers, VP and Head of Global Site and Study Operations at Pfizer, discusses Pfizer’s partnership with Parexel and transition to a functional service provider (FSP) model.
Related Posts
eCOA Flexibility in Clinical Trials: The Site Perspective
Image Credit: © Sergey Nivens – stock.adobe.com As medical product development drives advances in medical knowledge, clinical trials continue to…
Zai Lab and Novocure Share Positive Results from Phase III Clinical Trial for Pancreatic Cancer
Image Credit: © Matthieu – stock.adobe.com Zai Lab and Novocure have announced positive results from the Phase III PANOVA-3 clinical…
Xtandi Shows Superior Survival Outcomes to Abiraterone in Treatment of Metastatic Castration-Resistant Prostate Cancer
Image credit: Dr_Microbe | stock.adobe.com A retrospective, multicenter cohort study found that Xtandi (enzalutamide) achieved small but statistically significant improvements…